Influence of Polymorphisms in the ATP6V1 Gene of the V-ATPase on the Development of Incomplete Distal Renal Tubular Acidosis

NCT01690039 — Completed, 170 participants, Insel Gruppe AG, University Hospital Bern

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Comparison of Furosemide/Fludrocortisone With Ammonium Chloride Loading Test in the Diagnosis of Incomplete dRTA in Kidney Stone Formers

RegistryNCT01690039
StatusCompleted
Study typeObservational
Enrollment170 (Actual)
SponsorInsel Gruppe AG, University Hospital Bern (Other)
ConditionsAcidosis, Renal Tubular, Nephrolithiasis, Vacuolar Proton-Translocating ATPases
InterventionsFurosemide-Fludrocortisone-Test (test for urinary acidification) (Drug)
Datesstart 2012-09-01, primary completion 2016-12-31, completion 2017-05-12, first posted 2012-09-21, last updated 2018-10-09
Locations1 site in Switzerland

Related Papers Related Patents Related Grants Related Experts
All trials for Acidosis, Renal Tubular All trials for Nephrolithiasis All trials of Furosemide-Fludrocortisone-Test (test for urinary acidification)

-Summary

Purpose

1. To compare the performance of the two currently employed urinary acidifications tests in stone formers, the furosemide/fludrocortisone and ammonium chloride loading test.
2. To study the impact of polymorphisms in the genes ATP6V1B1, ATP6V0A4 and SLC4A1 on urinary acidification in stone formers.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
All study participantsDrug: Furosemide-Fludrocortisone-Test (test for urinary acidification)Furosemide-Fludrocortisone-Test and Ammonium chloride-Loading Test will be performed in renal stone patients.
  • Furosemide-Fludrocortisone-Test (test for urinary acidification) (Drug), also known as Application of Furosemide (Lasix® ) and Fludrocortisone (Florinef®): The presence of a lack of urinary acidification will be assessed by an appropriate test in all patients.

+Outcome measures

Primary outcomes

  • Capability of urinary acidification [Five to six hours]

Secondary outcomes

  • Polymorphisms in the ATP6V1 gene [12 months]

+Eligibility

Sex: All, ages: 18 Years to any, accepts healthy volunteers

Inclusion Criteria:

* One or more episodes of nephrolithiasis

Exclusion Criteria:

* Absence of informed consent
* All conditions affecting renal acidification
* Pregnancy
* Nursing

+Locations (1)

FacilityCityCountryStatus
Department of Nephrology and Hypertension, Bern University HospitalBernSwitzerland

+Investigators